- Home
- PTIX vs ONFO Comparison
PTIX vs ONFO Comparison
Compare PTIX & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- ONFO
- Stock Information
- Founded
- PTIX 1994
- ONFO 2018
- Country
- PTIX United States
- ONFO United States
- Employees
- PTIX N/A
- ONFO N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- ONFO Computer Software: Programming Data Processing
- Sector
- PTIX Health Care
- ONFO Technology
- Exchange
- PTIX Nasdaq
- ONFO Nasdaq
- Market Cap
- PTIX 3.9M
- ONFO 4.5M
- IPO Year
- PTIX 2016
- ONFO 2022
- Fundamental
- Price
- PTIX $0.64
- ONFO $1.30
- Analyst Decision
- PTIX
- ONFO
- Analyst Count
- PTIX 0
- ONFO 0
- Target Price
- PTIX N/A
- ONFO N/A
- AVG Volume (30 Days)
- PTIX 247.6K
- ONFO 24.9K
- Earning Date
- PTIX 11-29-2024
- ONFO 11-15-2024
- Dividend Yield
- PTIX N/A
- ONFO N/A
- EPS Growth
- PTIX N/A
- ONFO N/A
- EPS
- PTIX N/A
- ONFO N/A
- Revenue
- PTIX N/A
- ONFO $6,590,171.00
- Revenue This Year
- PTIX N/A
- ONFO $133.59
- Revenue Next Year
- PTIX N/A
- ONFO N/A
- P/E Ratio
- PTIX N/A
- ONFO N/A
- Revenue Growth
- PTIX N/A
- ONFO 29.25
- 52 Week Low
- PTIX $0.49
- ONFO $0.39
- 52 Week High
- PTIX $1.87
- ONFO $1.80
- Technical
- Relative Strength Index (RSI)
- PTIX 49.61
- ONFO 58.89
- Support Level
- PTIX $0.52
- ONFO $1.04
- Resistance Level
- PTIX $1.09
- ONFO $1.15
- Average True Range (ATR)
- PTIX 0.15
- ONFO 0.13
- MACD
- PTIX 0.01
- ONFO -0.01
- Stochastic Oscillator
- PTIX 20.91
- ONFO 62.00
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.